Veeva Systems Inc (NYSE:VEEV) shares are taking a hit in premarket trading, dropping by 2.89% to $219.00 following the release of their fourth-quarter FY24 results. Despite a strong 12% year-over-year revenue increase to $630.6 million, which exceeded expectations, the stock is facing a decline. The company also impressed investors with an adjusted EPS of $1.38 and a 14% increase in adjusted operating income to $239.1 million.
Looking forward, Veeva Systems is forecasting first-quarter revenue between $640 million and $643 million, with adjusted EPS expected to fall between $1.42 and $1.43 – slightly below what the market had predicted. For the fiscal year 2025, the company anticipates an adjusted EPS of $6.16 (compared to an estimated $5.57) and revenues ranging from $2.725 billion to $2.740 billion, which is lower than previously expected.
Despite the positive financial results and optimistic outlook for future earnings and growth, the market is reacting negatively to Veeva Systems’ performance, with share value decreasing in premarket trading.
Veeva Systems Inc. (VEEV) Shows Strong Price Momentum and Financial Performance in Healthcare Technology Sector
On March 1, 2024, Veeva Systems Inc. (VEEV) saw mixed performances in the stock market. The company’s stock was trading near the top of its 52-week range and above its 200-day simple moving average, indicating strong price momentum. Despite the drop in pre-market trading, Veeva Systems Inc. has been a strong performer in the healthcare technology sector. Investors have been bullish on VEEV stock due to its consistent growth and strong financial performance. Overall, VEEV’s strong price momentum, along with its solid financial performance, positions the company well for future growth in the healthcare technology sector. Investors may want to keep a close eye on VEEV stock to see how it performs in the coming days and weeks.
VEEV Stock Soars with 16.44% Increase in Total Revenue: A Promising Investment Opportunity in Healthcare Technology Sector
On March 1, 2024, VEEV stock showed strong performance based on the latest financial data provided by CNN Money. The company reported a total revenue of $2.15 billion for the past year, which represents a 16.44% increase compared to the previous year. In the third quarter alone, VEEV generated $616.50 million in revenue, marking a 4.45% increase from the previous quarter.
In terms of net income, VEEV reported $487.71 million for the past year, showing a 14.11% increase from the previous year. In the third quarter, the company’s net income was $135.16 million, reflecting a significant 21.08% increase from the previous quarter.
Earnings per share (EPS) also saw positive growth, with VEEV reporting an EPS of $3.00 for the past year, representing a 14.0% increase from the previous year. In the third quarter, the company’s EPS was $0.83, showing a substantial 20.73% increase from the previous quarter.
Overall, VEEV’s strong financial performance indicates that the company is on a growth trajectory. Investors may view these positive financial indicators as a sign of VEEV’s ability to generate revenue and increase profitability. As a result, VEEV stock may be considered an attractive investment option for those looking to capitalize on the company’s continued success in the healthcare technology sector.
